New drug combo aims to slow advanced breast cancer
Disease control
Recruiting now
This study tests two different doses of the drug dalpiciclib combined with letrozole in 120 women with a specific type of advanced breast cancer (HR-positive, HER2-negative). The goal is to see how long the cancer stays under control. Participants are randomly assigned to one of …
Phase: PHASE2 • Sponsor: wanghaibo • Aim: Disease control
Last updated May 17, 2026 03:53 UTC